Novel detection assay by PCR???RFLP and frequency of the CYP3A5 SNPs, CYP3A5 *3 and *6, in a Japanese population
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 12 (4), 331-334
- https://doi.org/10.1097/00008571-200206000-00009
Abstract
In this study, we established useful and reliable methods for the direct detection of the variants of CYP3A5 gene by polymerase chain reaction (PCR) and Dde I restriction analysis. The frequency of CYP3A5 related SNPs in 200 healthy Japanese male subjects was determined. The homozygous wild-type (*1/*1) frequency was 7.0% (14/200), the heterozygous (*1/*3) frequency was 32.5% (65/200) and the homozygous mutant-type (*3/*3) frequency was 60.5% (121/200). The *6 allele was not detected in any of the Japanese individuals. This result suggests that an estimated 40% of the Japanese express relatively high levels of metabolically active CYP3A5 protein. The proposed detection assays are useful for screening the CYP3A5 related SNPs in pharmacogenetic research.Keywords
This publication has 9 references indexed in Scilit:
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionNature Genetics, 2001
- Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A genePharmacogenetics, 2001
- cDNA Cloning and Initial Characterization of CYP3A43, a Novel Human Cytochrome P450Molecular Pharmacology, 2001
- Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.Published by Rockefeller University Press ,2000
- No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteinsBiochemical Pharmacology, 1999
- Ethnic Differences in Drug Disposition and ResponseTherapeutic Drug Monitoring, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamilyBiochemical Pharmacology, 1994
- Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human LiverJournal of Biological Chemistry, 1989